Clinical Trial Update: A Trial of Tocilizumab in ALS Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial of tocilizumab in ALS completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Barrow Neurological Institute | Conditions: ALS, Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-18